Senior insider sale
EVP & Co-Head Research & Inv. at ROYALTY PHARMA PLC — senior position signals high conviction
$982.9K
17.35K shares
What this filing means
URIST MARSHALL plans to sell 17.35K shares of ROYALTY PHARMA PLC valued at approximately $982.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/5/2026ACC: 0001964306-26-000465
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
17.35K
Shares to sell
$982.9K
Approx. market value
4.13K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Equity Performance Award
Granted as part of issuer equity compensation program
8/7/2026
4.13KTotal acquired4.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/7/2026 | Equity Performance Award Granted as part of issuer equity compensation program | 4.13K | — |
| Total | 4.13K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
4.13K
Market value
$238.8K
9/28/2026
—Completed
Units to sell
9.10K
Market value
$508.5K
7/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.13K
Market value
$235.6K
10/5/2026
Total
Units
17.35K
Value
$982.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/28/2026 | 4.13K | $238.8K | — | Completed |
7/1/2026 | 9.10K | $508.5K | — | Completed |
| Planned — Approximate Date | ||||
10/5/2026 | 4.13K | $235.6K | NASDAQ | Planned |
| Total | 17.35K | $982.9K | ||